P&G Raises Forecast On Strong First Half, Notes Price Increases As Potential Drag
Executive Summary
P&G reports 4% organic growth in its fiscal 2019 Q2, building on a strong Q1 and prompting it to raise full-year organic guidance 1%. CFO Jon Moeller warns, however, possible market volatility and competitor activity related to potential price increases could sink its positive estimate.
You may also be interested in...
P&G Begins US Price Increases In Baby And Feminine Care, Could Expand To Health, Beauty
P&G plans up to double-digit price increases in US baby care, feminine care and adult incontinence and will analyze raw material costs and foreign exchange impacts in its other product categories for other pricing changes.
P&G Ups Forecast On Beauty, Health Results, Despite 'A Lot Of Variability'
P&G beauty division's sales grow on premium skin care lines and despite price increases as health care sales grow 5% on volume, particularly in oral care. Net earnings in latest quarter grow 9% to $2.78bn as results prompt investor activity with share price slipping 2.7% in trading at nearly twice average volume.
Unilever Grows European Portfolio, P&G Trims More Brands In Toothpaste Deal
Fluocaril and Parogencyl are “well-known” toothpastes that have garnered “strong endorsement from health professionals,” Unilever says. The brands, identified by analysts as potential candidates for sale, are latest in P&G’s ongoing trimming of lower-selling lines.